Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

240
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
240
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

334
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
334
Drug Therapy01:28

Drug Therapy

45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
45

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Editorial: Dynamics of endocrine system dysfunctions and neuro-ophthalmic manifestations: early diagnostic to therapeutic implications.

Frontiers in endocrinology·2026
Same author

Mediator subunit MED4 enforces metastatic dormancy in breast cancer.

Nature cell biology·2026
Same author

Characterizing Multifunctional Mesoporous Cerium Silicate Nanoparticles for Potential Use in Bioactive Dental Materials: A Proof-of-Concept Study.

Materials (Basel, Switzerland)·2026
Same author

LFA-1 interaction with GBP-130 on <i>Plasmodium falciparum</i>-infected red blood cells mediates NK cell activation and parasite control.

eLife·2026
Same author

Corrigendum to "The posterity of Zebrafish in paradigm of in vivo molecular toxicological profiling" [Biomed. Pharmacother. 171 (2024) 116160].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Unusual sub-mitral location of intracardiac thrombus: a rare presentation in hypereosinophilic syndrome.

The international journal of cardiovascular imaging·2026

相关实验视频

Updated: Jul 8, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K

对结核病的宿主导疗法:概念和最近的发展.

Sonakshi Udinia1, Mrutyunjay Suar, Dhiraj Kumar

  • 1Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi 110067, India.

Journal of biosciences
|December 13, 2023
PubMed
概括
此摘要是机器生成的。

耐药结核病 (TB) 需要新的治疗方法. 宿主导疗法 (HDT) 通过向宿主机制提供了一个有希望的策略,有可能克服抗菌素耐药性 (AMR) 和超级细菌.

更多相关视频

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K

相关实验视频

Last Updated: Jul 8, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K

科学领域:

  • 微生物学 微生物学
  • 免疫学 免疫学 免疫学
  • 传染性疾病 传染性疾病

背景情况:

  • 结核病 (TB) 仍然是一个全球卫生挑战,由抗菌素耐药性 (AMR) 加剧.
  • 由于COVID-19大流行,结核病控制工作受到干扰.
  • 耐药结核病的出现需要超越传统抗生素的新疗法策略.

研究的目的:

  • 审查参与结核病发病的宿主机制.
  • 讨论宿主导疗法 (HDT) 作为抗生素补充策略的潜力.
  • 突出挑战和最近的发展,以确定结核病治疗的宿主目标.

主要方法:

  • 对结核病中的宿主-病原体相互作用的文献综述.
  • 对宿主导疗法方法的分析.
  • 检查受Mycobacterium结核病菌利用的宿主通道.

主要成果:

  • 主体导向疗法 (HDT) 提供了一种解除Mycobacterium结核病的方法,防止耐药性.
  • 高强度结核治疗可以克服对抗多药耐药结核病菌株药物短缺的挑战.
  • 鉴定HDT的有效宿主目标仍然是一个重大挑战,尽管取得了进展.

结论:

  • 宿主导疗法 (HDT) 为开发新的结核病治疗方法提供了一个有希望的途径.
  • 准宿主途径对于克服结核病中的抗菌素耐药性 (AMR) 是至关重要的.
  • 需要进一步的研究来识别和验证宿主目标,以便有效地实施针对结核病的高强度治疗策略.